Literature DB >> 35157222

Down-regulation of microRNA-155 suppressed Candida albicans induced acute lung injury by activating SOCS1 and inhibiting inflammation response.

Xiaohua Li1,2, Yuanzhong Gong3, Xin Lin1, Qiong Lin1, Jianxiong Luo1, Tianxing Yu1, Junping Xu1, Lifang Chen1, Liyu Xu4, Ying Hu5.   

Abstract

Acute lung injury caused by Candida albicans could result in high mortality and morbidity. MicroRNA-155 (miR-155) and suppressor of cytokine signaling 1 (SOCS1) have been believed to play a key in the regulation of inflammatory response. Whether miR-155/SOCS1 axis could regulate the acute lung injury caused by C. albicans has not been reported. The acute lung injury animal model was established with acute infection of C. albicans. miR-155 inhibitor, miR-155 mimic, and sh-SOCS1 were constructed. The binding site between miR-155 and SOCS1 was identified with dual luciferase reporter assay. Knockdown of miR-155 markedly inhibited the germ tube formation of C. albicans. Knockdown of miR-155 significantly up-regulated the expression of SOCS1, and the binding site between miR-155 and SOCS1 was identified. Knockdown of miR-155 improved the acute lung injury, suppressed inflammatory factors and fungus loading through SOCS1. Knockdown of SOCS1 greatly reversed the influence of miR-155 inhibitor on the cell apoptosis in vitro. The improvement of acute lung injury caused by C. albicans, suppression of inflammatory response and C. albicans infection, and inhibitor of cell apoptosis were achieved by knocking down miR-155 through SOCS1. This research might provide a new thought for the prevention and treatment of acute lung injury caused by C. albicans through targeting miR-155/SOCS1 axis.
© 2022. The Microbiological Society of Korea.

Entities:  

Keywords:  Candida albicans; SOCS1; acute lung injury; miR-155

Mesh:

Substances:

Year:  2022        PMID: 35157222      PMCID: PMC8853013          DOI: 10.1007/s12275-022-1663-5

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   2.902


  33 in total

1.  Experimental Candida albicans osteomyelitis: Microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model.

Authors:  Maria N Gamaletsou; Joseph Meletiadis; Sofia Chatziioannou; Ioannis G Panayiotides; Euthimios Agadakos; Michalis Katsimpoulas; Nikolaos Kostomitsopoulos; Vidmantas Petraitis; Thomas J Walsh; Nikolaos V Sipsas
Journal:  Med Mycol       Date:  2019-11-01       Impact factor: 4.076

2.  Downregulation of miR-27a* and miR-532-5p and upregulation of miR-146a and miR-155 in LPS-induced RAW264.7 macrophage cells.

Authors:  Ying Cheng; Wenhua Kuang; Yongchang Hao; Donglin Zhang; Ming Lei; Li Du; Hanwei Jiao; Xiaoru Zhang; Fengyang Wang
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling.

Authors:  Sébastien Gingras; Evan Parganas; Antoine de Pauw; James N Ihle; Peter J Murray
Journal:  J Biol Chem       Date:  2004-10-18       Impact factor: 5.157

4.  Allergen challenge induces Ifng dependent GTPases in the lungs as part of a Th1 transcriptome response in a murine model of allergic asthma.

Authors:  Nilesh Dharajiya; Swapnil Vaidya; Mala Sinha; Bruce Luxon; Istvan Boldogh; Sanjiv Sur
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

5.  Dectin-1 is required for miR155 upregulation in murine macrophages in response to Candida albicans.

Authors:  Daniel Paiva Agustinho; Marco Antônio de Oliveira; Aldo Henrique Tavares; Lorena Derengowski; Valentina Stolz; Fernanda Guilhelmelli; Márcia Renata Mortari; Karl Kuchler; Ildinete Silva-Pereira
Journal:  Virulence       Date:  2016-06-13       Impact factor: 5.882

6.  AT-RvD1 modulates CCL-2 and CXCL-8 production and NF-κB, STAT-6, SOCS1, and SOCS3 expression on bronchial epithelial cells stimulated with IL-4.

Authors:  Jhony Robison de Oliveira; Daniely Cornélio Favarin; Sarah Cristina Sato Vaz Tanaka; Marly Aparecida Spadotto Balarin; David Nascimento Silva Teixeira; Bruce David Levy; Alexandre de Paula Rogério
Journal:  Biomed Res Int       Date:  2015-05-05       Impact factor: 3.411

Review 7.  Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy.

Authors:  Shunsuke Chikuma; Mitsuhiro Kanamori; Setsuko Mise-Omata; Akihiko Yoshimura
Journal:  Cancer Sci       Date:  2017-04-19       Impact factor: 6.716

8.  Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.

Authors:  Darius Juskevicius; David Jucker; Dirk Klingbiel; Christoph Mamot; Stephan Dirnhofer; Alexandar Tzankov
Journal:  J Hematol Oncol       Date:  2017-03-17       Impact factor: 17.388

Review 9.  Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury.

Authors:  Jiang Du; Han Li; Jie Lian; Xinxing Zhu; Liang Qiao; Juntang Lin
Journal:  Stem Cell Res Ther       Date:  2020-05-24       Impact factor: 6.832

10.  Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.

Authors:  Mohamed K Hassan; Amr A Waly; Waheba Elsayed; Sarah Keshk; Walaa Ramadan Allam; Sherif F El-Khamisy
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.